Michael J. Moritz - 02 Oct 2023 Form 4 Insider Report for Bruker Cellular Analysis, Inc.

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
03 Oct 2023, 14:37:49 UTC
Prior SEC filing
25 Sep 2023
Next SEC filing
31 May 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Christine Nassi, Attorney-in-fact for Michael J. Moritz

Key filing fact

Michael J. Moritz filed Form 4 for Bruker Cellular Analysis, Inc. on 03 Oct 2023.

Key facts

  • This page summarizes Michael J. Moritz's Form 4 filing for Bruker Cellular Analysis, Inc..
  • 9 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 03 Oct 2023, 14:37.

Change

  • Previous filing in this sequence was filed on 25 Sep 2023.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CELL transaction

Common Stock

Options Exercise

Transaction value
Shares
-70,000
Change %
-29%
Price
Shares after
174,662
Date
02 Oct 2023
Ownership
By estate planning vehicle
Footnotes
F1, F2
CELL transaction

Common Stock

Disposed to Issuer

Transaction value
Shares
-174,662
Change %
-100%
Price
Shares after
0
Date
02 Oct 2023
Ownership
By estate planning vehicle
Footnotes
F3, F4
CELL transaction

Common Stock

Disposed to Issuer

Transaction value
Shares
-755,670
Change %
-100%
Price
Shares after
0
Date
02 Oct 2023
Ownership
Sequoia Capital U.S. Growth Fund VI, L.P.
Footnotes
F3, F4, F5, F6
CELL transaction

Common Stock

Disposed to Issuer

Transaction value
Shares
-47,432
Change %
-100%
Price
Shares after
0
Date
02 Oct 2023
Ownership
Sequoia Capital U.S. Growth VI Principals Fund, L.P.
Footnotes
F3, F4, F5, F6
CELL transaction

Common Stock

Disposed to Issuer

Transaction value
Shares
-279,214
Change %
-100%
Price
Shares after
0
Date
02 Oct 2023
Ownership
Sequoia Capital U.S. Venture Fund XV, L.P.
Footnotes
F3, F4, F5, F6
CELL transaction

Common Stock

Disposed to Issuer

Transaction value
Shares
-6,035
Change %
-100%
Price
Shares after
0
Date
02 Oct 2023
Ownership
Sequoia Capital U.S. Venture Partners Fund XV, L.P.
Footnotes
F3, F4, F5, F6
CELL transaction

Common Stock

Disposed to Issuer

Transaction value
Shares
-16,805
Change %
-100%
Price
Shares after
0
Date
02 Oct 2023
Ownership
Sequoia Capital U.S. Venture Partners Fund XV (Q), L.P.
Footnotes
F3, F4, F5, F6
CELL transaction

Common Stock

Disposed to Issuer

Transaction value
Shares
-61,325
Change %
-100%
Price
Shares after
0
Date
02 Oct 2023
Ownership
Sequoia Capital U.S. Venture XV Principals Fund, L.P.
Footnotes
F3, F4, F5, F6
CELL transaction

Common Stock

Disposed to Issuer

Transaction value
Shares
-110,782
Change %
-100%
Price
Shares after
0
Date
02 Oct 2023
Ownership
By Sequoia Grove II, LLC
Footnotes
F3, F4, F5, F6
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 6 footnotes

Footnote F1

On October 2, 2023, pursuant to the Agreement and Plan of Merger dated as of August 17, 2023 (the "Merger Agreement"), by and among Bruker Corporation ("Bruker"), Bird Mergersub Corporation ("Merger Sub") and Phenomex Inc. (the "Company"), Merger Sub merged with and into the Company, with the Company surviving the Merger as a wholly owned subsidiary of Bruker (the "Merger"), and each restricted stock unit ("RSU") held by the Reporting Person was cancelled and converted into the right to receive $1.00 per share in cash (the "Merger Consideration").

Footnote F2

Pursuant to the Merger, the Reporting Person disposed of each RSU held by him in exchange for the Merger Consideration.

Footnote F3

Pursuant to the Merger Agreement, each outstanding share of Common Stock, par value $0.00005 per share ("Common Stock") held by the Reporting Person was cancelled and converted into the right to receive the Merger Consideration.

Footnote F4

Pursuant to the Merger, the Reporting Person disposed of all shares of Common Stock beneficially owned by him in exchange for the Merger Consideration.

Footnote F5

The Reporting Person is a director and stockholder of SC US (TTGP), Ltd., which is the general partner of SC U.S. Venture XV Management, L.P., which is the general partner of Sequoia Capital U.S. Venture Fund XV, L.P., Sequoia Capital U.S. Venture Partners Fund XV, L.P., Sequoia Capital U.S. Venture Partners Fund XV (Q), L.P., and Sequoia Capital U.S. Venture XV Principals Fund, L.P. (collectively, the "SC XV Funds") and the general partner of SC U.S. Growth VI Management, L.P., which is the general partner of Sequoia Capital U.S. Growth Fund VI, L.P. and Sequoia Capital U.S. Growth VI Principals Fund, L.P. (collectively, the "SC US GF VI Funds").

Footnote F6

(Continue from footnote 5) As a result, the Reporting Person may be deemed to share beneficial ownership of the shares held by the SC XV Funds and the SC US GF VI Funds. The Reporting Person disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .